Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux
暂无分享,去创建一个
C. Sensen | M. Hayden | A. Brooks-Wilson | J. Kastelein | K. Roomp | B. F. Ouellette | J. Collins | J. Genest | K. Fichter | Lin-hua Zhang | M. Marcil | S. M. Clee | M. Dam | Lu Yu | H. Molhuizen | S. Mott | M. Denis | S. Pimstone | B. Boucher | Odell Loubster | Stephanie Mott
[1] Thomas L. Madden,et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.
[2] D. Rader,et al. Familial HDL deficiency due to marked hypercatabolism of normal apoA-I. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[3] S. Eisenberg,et al. High density lipoprotein metabolism. , 1984, Journal of lipid research.
[4] J. Lupski,et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Starqardt macular dystrophy , 1997, Nature Genetics.
[5] K Rohrschneider,et al. Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR. , 1998, Human molecular genetics.
[6] W. Willett,et al. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.
[7] P. Talmud,et al. Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: The European Atherosclerosis Research Study , 1994, Genetic epidemiology.
[8] Richard H. Myers,et al. Familial Lipoprotein Disorders in Patients With Premature Coronary Artery Disease , 1992, Circulation.
[9] J. Zieleński,et al. Cystic fibrosis: genotypic and phenotypic variations. , 1995, Annual review of genetics.
[10] M. Tremblay,et al. Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[11] M. Hayden,et al. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis , 1995, Nature Genetics.
[12] G. Assmann,et al. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. , 1997, Journal of lipid research.
[13] André Rosenthal,et al. Large-scale production of DNA sequencing templates by microtitre format PCR , 1993, Nucleic Acids Res..
[14] Alan D. Lopez,et al. Mortality by cause for eight regions of the world: Global Burden of Disease Study , 1997, The Lancet.
[15] C. Sensen,et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.
[16] Jean Mosser,et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters , 1993, Nature.
[17] M. Freeman,et al. Decreased cholesterol efflux from fibroblasts of a patient without Tangier disease, but with markedly reduced high density lipoprotein cholesterol levels. , 1998, The Journal of clinical endocrinology and metabolism.
[18] T. Langmann,et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.
[19] G. Rogler,et al. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[20] Paul S. Bernstein,et al. Mutation of the Stargardt Disease Gene (ABCR) in Age-Related Macular Degeneration , 1997 .
[21] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[22] Andreas D. Baxevanis,et al. Bioinformatics - a practical guide to the analysis of genes and proteins , 2001, Methods of biochemical analysis.
[23] K. Ueda,et al. Amino acid substitutions in the first transmembrane domain (TM1) of P‐glycoprotein that alter substrate specificity , 1997, FEBS letters.
[24] J. Frohlich,et al. Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[25] J. Genest,et al. Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[26] J. Little,et al. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. , 1982, Atherosclerosis.
[27] H. Moser,et al. Mutations in the 70K peroxisomal membrane protein gene in Zellweger syndrome , 1992, Nature Genetics.
[28] G. Schuler,et al. Sequence alignment and database searching. , 2001, Methods of biochemical analysis.
[29] S. Sakisaka,et al. [Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome]. , 1999, Fukuoka igaku zasshi = Hukuoka acta medica.
[30] J. Boer,et al. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[31] A. Mendez,et al. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux. , 1993, The Journal of clinical investigation.
[32] J. Piette,et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.
[33] I. Pastan,et al. Genetic analysis of the multidrug transporter. , 1995, Annual review of genetics.
[34] S. Kane,et al. Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein. , 1997, Biochemistry.